" class="no-js "lang="en-US"> Biosyntia - Medtech Alert
Wednesday, September 03, 2025
Biosyntia | Pharmtech Focus

Biosyntia

About Biosyntia

Biosyntia

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at a startup incubator (Symbion) in Copenhagen, just a few kilometers from the center of the city.

Related Story

Biosyntia Closes a 11.5 Million EUR Round to Launch World’s First Bio-based Vitamin B7

July 7 2022

Biosyntia has secured a Series B funding round of 11.5 million euros from a strong […]